NASDAQ | ETF
The fund normally invests at least 80% of assets in securities of disruptive medicine companies.
Fidelity's disruptive strategies seek to identify innovative developments that could signal new directions for delivering products and services to customers.
Generally, these companies have or are developing new or unconventional ways of doing business that could disrupt and displace incumbents over time.
The fund is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| BSX | Boston Scientific Corp | Healthcare | Medical Devices | 5.57% |
| ALNY | Alnylam Pharmaceuticals Inc | Healthcare | Biotechnology | 4.76% |
| ARGX | argenx NV ADR | Healthcare | Biotechnology | 3.88% |
| VEEV | Veeva Systems Inc Class A | Healthcare | Health Information Services | 3.65% |
| DHR | Danaher Corporation | Healthcare | Diagnostics & Research | 3.44% |
| PODD | Insulet Corporation | Healthcare | Medical Devices | 3.28% |
| UCB | UCB SA | Healthcare | Biotechnology | 3.22% |
| LEGN | Legend Biotech Corp | Healthcare | Biotechnology | 3.15% |
| WAY | Waystar Holding Corp. Common Stock | Healthcare | Health Information Services | 3.13% |
| PEN | Penumbra Inc | Healthcare | Medical Devices | 3.00% |
| ISRG | Intuitive Surgical Inc | Healthcare | Medical Instruments & Supplies | 2.92% |
| EXAS | EXACT Sciences Corporation | Healthcare | Diagnostics & Research | 2.76% |
| SYK | Stryker Corporation | Healthcare | Medical Devices | 2.58% |
| EW | Edwards Lifesciences Corp | Healthcare | Medical Devices | 2.57% |
| MASI | Masimo Corporation | Healthcare | Medical Devices | 2.48% |
| DIM | Sartorius Stedim Biotech SA | Healthcare | Medical Instruments & Supplies | 1.98% |
| RPRX | Royalty Pharma Plc | Healthcare | Biotechnology | 1.88% |
| DXCM | DexCom Inc | Healthcare | Medical Devices | 1.84% |
| MRK | Merck & Company Inc | Healthcare | Drug Manufacturers - General | 1.83% |
| LLY | Eli Lilly and Company | Healthcare | Drug Manufacturers - General | 1.81% |